Charles River Newsroom

Stephens Adjusts Price Target on Charles River Laboratories International to $250 From $280

MT NewswiresJul 16 09:10 ET

Charles River Analyst Ratings

BenzingaJul 10 08:15 ET

Charles River Analyst Ratings

BenzingaJun 28 08:22 ET

Charles River Analyst Ratings

BenzingaJun 7 06:42 ET

Charles River Analyst Ratings

BenzingaJun 6 08:58 ET

Charles River Analyst Ratings

BenzingaMay 13 12:20 ET

Charles Rhyee Maintains Hold on Charles River Labs Amidst Revenue and Market Uncertainties

TipRanksMay 12 21:00 ET

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Plus Therapeutics (PSTV) and Argenx Se (ARGX)

TipRanksMay 10 08:45 ET

Charles River Analyst Ratings

BenzingaMay 10 07:22 ET

Evercore ISI Adjusts Price Target on Charles River Laboratories International to $265 From $300

MT NewswiresMay 10 06:15 ET

Buy Rating on Charles River Labs Amidst Solid Q1 Performance and Positive Market Outlook

TipRanksMay 10 05:10 ET

Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Charles River Labs (CRL) and Neurocrine (NBIX)

TipRanksMay 1 08:20 ET

Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278

MT NewswiresApr 12 10:22 ET

Deutsche Bank Raises Price Target on Charles River Laboratories to $300 From $275, Keeps Buy Rating

MT NewswiresMar 22 11:38 ET

Charles River Analyst Ratings

BenzingaMar 18 10:13 ET

Morgan Stanley Raises Price Target on Charles River Laboratories International to $235 From $205, Keeps Equalweight Rating

MT NewswiresFeb 16 07:50 ET

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Charles River Labs (CRL) and Shockwave Medical (SWAV)

TipRanksFeb 16 07:20 ET

Evercore ISI Remains a Buy on Charles River Labs (CRL)

TipRanksFeb 15 19:25 ET

Baird Adjusts Price Target on Charles River Laboratories International to $268 From $252, Maintains Outperform Rating

MT NewswiresFeb 15 10:23 ET

Charles River Analyst Ratings

BenzingaFeb 15 08:01 ET